Pancreatic Cancer Lawsuit Settlements
Early diagnosis of pancreatic cancer is not easy due to its aggressive nature. The prognosis of Pancreatic cancer railroad lawsuits cancer depends on the stage at which the cancer, whether it can be surgically removed, and what other treatment options are available.
If you or someone you know developed pancreatic cancer caused by railroad how to get a settlement cancer kidney damage, pancreatic cancer or another serious condition after taking Prilosec or Nexium, you may be eligible to file a PPI lawsuit. Find out more information about filing the claim.
Januvia and Janumet Lawsuits
The Januvia pancreatic cancer lawsuits assert that Merck put profit ahead of consumer safety when it came to marketing the diabetes drug. Januvia is Merck’s most-sold drug has earned more than $5 billion in sales.
Many studies, both academic and post-marketing, suggest an association between incretin mimetics like Januvia (sitagliptin) and Pancreatic cancer lawsuit settlement cancer. This is a serious worry, since pancreatic carcinoma is usually in a advanced stage at the time of diagnosis, and there are a few effective treatments available.
The lawsuits brought by the families of victims of pancreatic cancer have been named Merck, Amylin Pharmaceuticals, Eli Lilly and Bristol-Myers Squibb as defendants. The lawsuits assert that the companies knew or should have known that their Type 2 diabetes medications could cause pancreatic cancer, but did not adequately warn doctors and patients about this risk.
In 2016, the court consolidated Januvia, Byetta, and Janumet lawsuits in a multi-district litigation case under Judge Anthony Battaglia. The plaintiffs won a major victory in 2017, when the 9th Circuit Court of Appeals overturned a lower court decision which had dismissed the cases and reinstated the cases.
Those who took Januvia and were diagnosed with pancreatic cancer may be entitled to compensation for medical bills and lost earnings, funeral costs or pre-death suffering and pain damages and other losses. National Injury Help is reviewing potential lawsuits and offering a free consultations to those who are eligible.
Zantac Lawsuits
Zantac lawsuits began filing shortly after the FDA recalled the heartburn medication’s over-the-counter version in 2022 due to the discovery of cancer-causing N-nitrosodimethylamine (NDMA) contamination. After the discovery, more than 50k claims were filed with federal courts. The cases were then consolidated into a single multidistrict case before U.S. District Judge Robin Rosenberg in Florida. The plaintiffs claimed that Zantac’s manufacturers knew of the risks ranitidine had but failed to warn consumers. The lawsuits claim that the companies knew or should have be aware that the over the medicine was contaminated with NDMA and could cause esophageal, bladder and cancers of the gastrointestinal tract, liver and pancreatic. Others claim that the over-the-counter medication caused other side effects, such as ulcers and diarrhea.
The trial was set to begin in California this summer, and other trials in the MDL were scheduled to begin following that. The MDL judge dismissed the case in December 2022, after he concluded that the expert testimony of the plaintiffs was not reliable. The judge claimed that the evidence of science was insufficient and speculative to back the claims.
The ruling is a huge disappointment to plaintiffs’ hopes for justice and fair compensation for their losses. We are hopeful that the upcoming bellwether trial will give us an insight into the verdicts of juries that could be awarded in these cases. If the trials prove to be successful, it could encourage defendants to settle claims faster.
Camp Lejeune Lawsuits
The Camp Lejeune Marine Corps Base was affected by volatile organic compounds found in its drinking water. The water contamination caused serious health issues for lawsuit settlement those who lived or Lawsuit settlement worked at the Marine base. These diseases include cancers including bladder cancer, kidney cancer, multiple myeloma, Non-Hodgkin’s lymphoma and more. Our law firm can help you when you or a member of your family suffered injuries resulting from the water contamination in Camp Lejeune. Our highly experienced personal injury, product liability, and mass tort lawyers have over 130 years of experience. Our clients have recovered more than $250 million.
Anyone who was a resident or employee at Camp Lejeune for 30 days or longer during the time of contamination is eligible to submit a claim for compensation. Anyone who has a deceased family member who died of a disease believed to be connected to the contaminated drinking water at Camp Lejeune can also file the lawsuit for wrongful death.
The value of a claim for compensation is determined by the severity of the injury and the impact it has had on their standard of life. For example cases of kidney cancer will likely have a higher settlement value than a bladder cancer case. The cases of bladder cancer are, however, more compelling evidence that links them to the infected water at Camp Lejeune.
The Camp Lejeune litigation was consolidated into a multi-district litigation in the Eastern District of North Carolina Federal Court. The MDL will create a single complaint for all lawsuits. It will also set up processes to consolidate discovery motions related to coordinate experts and motions that disprove the coordinates.
Ranitidine Lawsuits
Millions of Americans use Zantac (and generic ranitidine) to treat acid reflux, ulcers and other stomach issues. It was among the most popular drugs until it was discovered that it could contain a cancer-causing chemical known as NDMA.
Since the discovery of NDMA in ranitidine, thousands of lawsuits have been filed against the firms that manufacture and distribute this popular medication. These lawsuits have been grouped together into a federal multidistrict Lawsuit settlement which is overseen by U.S. District judge Robin Rosenberg in the Southern District of Florida. In addition to the MDL numerous lawsuits have been filed in state court.
These lawsuits assert that the makers of ranitidine were aware NDMA but did not warn their users of its danger. If successful, plaintiffs could be awarded compensation for their injuries.
The defendants may try to keep a few of these claims out of court by claiming the evidence is not in line with certain legal standards. They will argue, in particular, that there isn’t enough evidence to suggest that NDMA found in Zantac could cause certain kinds of cancer. They might also argue that preexisting conditions like stomach polyps and obesity are responsible for the plaintiff’s cancer, rather than the NDMA in Zantac. However, if the plaintiff can prove that the cancer was caused by NDMA in Zantac then they could be able to be awarded compensation for their suffering.